CGM costs
From 1st July 2023, the Australian Government announced that the Guardian™ 4 Sensor will be subsidised for all Australians living with Type 1 diabetes.
Patient options
Your patient may be eligible for Guardian™ 4 Sensor through the NDSS CGM subsidy scheme. Find out if your patient is eligible here.
If not, your patient can purchase a Subscription giving access to discounted pricing for our CGM technology. Please read the descriptions carefully to ensure your patient to purchase the correct subscription for the technology your patient is using.
Subscriptions
$50 PER SENSOR + GUARDIAN™ 4
12 boxes per year$250 per month for 12 months
40% off RRP of $5,199
Save $2,199
References
ALWAYS FOLLOW THE DIRECTIONS FOR USE.
The MiniMed 780G insulin pump is indicated for use by patients age 7-80 years with Type 1 diabetes, whose total daily dose of insulin is 8 units per day or more. The MiniMed 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to provide an automatic adjustment of insulin delivery based on continuous glucose monitoring (CGM) and can suspend the delivery of insulin when the SG value falls below, or is predicted to fall below, predefined threshold values.